Accelerating Women’s Health Investment
Takeaways from the WHAM Roundtable
Sasha Kelemen, Director in Baird’s Global Healthcare Investment Banking Group, recently spoke on the WHAM Roundtable, The WHAM Report: The Business Case for Accelerating Women's Health Investment. Sasha, along with panelists from venture capital, translational science and private equity discussed the investment opportunities in women’s health. Topics from the roundtable included:
- How institutional investors and private equity can scale capital in women’s health
- The role of venture capital in scaling women’s health breakthroughs
- Promising areas in women’s health for innovation and returns
- How to create better incentives for investment for women’s health
- The factors that make a women’s health company attractive for institutional investment
Women’s health is an overlooked industry with untapped potential for returns and capitalizing on these investments can drive profitability and create competitive advantage for investors and companies. To learn more about these topics watch the full panel.
Interested in learning more about these topics? Connect with Baird’s Global Healthcare Investment Banking group to learn more.
